University of Southern California
USC Norris Comprehensive Cancer Center
If you are a patient, please contact Keck Medical Center of USC at 800-USC-CARE.

Trial 11S-17-1


PhII-148 A Phase 2 Study of Anti-PD-L1 Antibody (Atezolizumab) in Alveolar Soft Part Sarcoma

Type: Treatment
Phase: Phase II
Status: Open to Accrual
Treatments: Biological Response Modifier
Randomized: No
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  James Hu, M.D.
Other Trial Staff:  Kristy Watkins, Coordinator, Fahim Raian, D.M., Victoria Amran, D.M., Jiayi Jiang, D.M., Mary Ordaz, D.M., Gina Tse, Coordinator, Kristy Sartor Massopust, Coordinator, Noureddine Miloud, D.M., Shamim Jhimlee, Coordinator, Eduardo Mejia, D.M., Yanli Wang, D.M., Laurie De Oliveira, Coordinator, Niranjan Bhatt, D.M.

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.